Schválenie na základe klinického skúšania fázy 3 DeLLphi-304, ktoré preukázalo 40 % zníženie rizika úmrtia pri použití lieku IMDYLLTRA v porovnaní s chemoterapiou Nová možnosť liečby pre pacientov s pokročilým štádiom malobunkového karcinómu pľúc po progresii THOUSAND OAKS, Kalifornia, 3....
Hence then, the article about europska komisia schvalila liek imdylltra spolocnosti amgen na liecbu pokrocileho stadia malobunkoveho karcinomu pľuc was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( EURÓPSKA KOMISIA SCHVÁLILA LIEK IMDYLLTRA® SPOLOČNOSTI AMGEN NA LIEČBU POKROČILÉHO ŠTÁDIA MALOBUNKOVÉHO KARCINÓMU PĽÚC )
Also on site :
- What the hell happened to Christopher Nolan? The Odyssey casting backlash explained
- Fire burns in Kuwait after Iran launches drone and missile attack
- BURNHAM PARK CAPITAL MARKETS LAUNCHES AS CHICAGO'S NEWEST INVESTMENT BANK, WILL CONSOLIDATE FIVE SPECIALIZED FIRMS TO CREATE A FULL SERVICE PLATFORM